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MelanomaCells from a patient with a DNA repair-deﬁciency disorder are anticipated to bear a large number of somatic
mutations. Because such mutations occur independently in each cell, there is a high degree of mosaicism in
patients' tissues. While major mutations that have been expanded in many cognate cells are readily detected
by sequencing,minor ones are overlaidwith a large depth of non-mutated alleles and are not detected. However,
cell cloning enables us to observe such cryptic mutations as well as major mutations. In the present study, we
focused on a ﬁbroblastic cell line that is derived from a patient diagnosed with xeroderma pigmentosum (XP),
which is an autosomal recessive disorder caused by a deﬁciency in nucleotide excision repair. By making a list
of somatic mutations, we can expect to see a characteristic pattern of mutations caused by the hereditary
disorder. We cloned a cell by generating an iPS cell line and performed a whole-exome sequencing analysis of
the progenitor and its iPS cell lines. Unexpectedly, we failed to ﬁnd causal mutations in the XP-related genes,
but we identiﬁed many other mutations including homozygous deletion of GSTM1 and GSTT1. In addition, we
found that the long arm of chromosome 9 formed uniparental disomy in the iPS cell line, which was also con-
ﬁrmed by a structuralmutation analysis using a SNP array. Type and number of somaticmutationswere different
from those observed in XP patients. Taken together, we conclude that the patient might be affected by a different
type of the disorder and that some of themutations that we identiﬁed heremay be responsible for exhibiting the
phenotype. Sequencing and SNP-array data have been submitted to SRA and GEO under accession numbers
SRP059858 and GSE55520, respectively.
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Xeroderma pigmentosum (XP) is caused by a deﬁciency in base ex-
cision repair, resulting in a large number of single-nucleotidemutations,
especially in sun-exposed skin [1]. Due to the independent manner of
the occurrence of the somatic mutations, the patient tissue, including
ﬁbroblasts, may form a high degree of mosaicism. If a mutation had oc-
curred in an early stage of development or in stem cells, it could readily
be detected by DNA sequencing. Most of the mutations that have
occurred in skin cells would not be expandedmuch because the greater
part of the cells is rather differentiated. Hence, it seems difﬁcult to ob-
tain a genome-wide pattern of XP-derived mutations. However, it may
be possible to examine a whole set of mutations of a single cell if the
cell could be cloned. This can be achieved by generation of iPS cellsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
X
Y
Fig. 1.Genome-wide distribution of the somaticmutations identiﬁed in the present study.
Blue and red bars indicate single-nucleotide and indel mutations, respectively. Nearly one
thousand mutations were detected on the long arm of chromosome 9. The discrepant
genotypes between the progenitor and its iPS cell lines were caused by a single structural
mutation that formed uniparental disomy in the chromosome arm.
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that a number of de novo mutations arise during the reprogramming
process and cultivation after the establishment of an iPS cell line, but
many recent studies have demonstrated that most of the mutations
found in iPS cells were preexisting in their progenitor lines, suggesting
the high genetic stability of reprogramming and subsequent cultivation
[3,4]. In the present study, we focused on a ﬁbroblast cell line derived
from an XP patient and established its iPS cell lines in order to delineate
somatic mutations in the exome-target regions.
We obtained the XP40OS cell line, whichwas derived from a patient
diagnosed with XP group C, from the JCRB Cell Bank [5]. This study was
approved by the Institutional Review Board at the National Center for
Child Health and Development. Employing the samemethod described
in our previous study, we established its iPS cell line and performed
whole-exome sequencing and structural alteration analyses for both
the progenitor and iPS cell lines [6]. In brief, the iPS cells were generated
by reprogramming with Sendai virus infection-mediated expression of
the four factors. Extracted DNA samples were treated with Agilent
SureSelect Human All Exon V4+UTRs+lincRNA, whose target size
was approximately 80 Mb, to prepare a pair-end library. The library
was sequenced on the Illumina platform, yielding 18.8 Gb (93.3 M
read pairs) and 18.7 Gb (92.7 M read pairs) data, respectively. After
trimming, the data sizes were reduced to 16.9 Gb (84.3 M read pairs)
and 16.8 Gb (83.7 M read pairs). For both samples, over 99% bases had
q-scores that are more than 15. Our pipeline software included
cutadapt-1.7.1, BWA 0.7.12, SAMtools 1.2, Picard 1.130, Genome Analy-
sis Toolkit 3.3, and our own custom programs coded in C or Perl. Reads
were mapped to the hs37d5 (GRCh37) reference sequence and PCR
duplicate reads were then eliminated. Ratios of PCR duplicates were
27.4% and 26.5%, respectively. Along with in-house control data,
multi-sample calling of single-nucleotide and short indel variations
was performed. Filtration and identiﬁcation of somatic mutations
were carried out as described in our previous study [6].
First, we searched for possible variants that could affect the XP phe-
notype. Such variants should be found in both lines. A homozygous one
(rs1800975) was found in the 5′ untranslated region of the XPA gene
and two heterozygous ones (rs2228000 and rs2228001), which alter
amino acid sequences, were found in the protein-coding regions of the
XPC gene. Since their allelic frequencies in the population were not
rare (50.8%, 32.6%, and 60.6%, respectively, according to the Human
Genetic Variation Database, http://www.genome.med.kyoto-u.ac.jp/
SnpDB), they cannot be considered as etiologic variants.Whilewe failed
to ﬁnd any other notable variants in XP-related genes, we found homo-
zygous deletions in the BTNL3, GSTM1, GSTT1, and SLC25A24 loci. The
GSTM1 and GSTT1 genes lacked the entire coding regions. The list of all
possible variants is available from the websites (see the “Direct link to
deposited data” section).
Next, we searched for inconsistent genotypes called with
UniﬁedGenotyper between the progenitor and its iPS cell lines to iden-
tify somatic mutations. Using the criteria described in our previous
study [6], 922 single-nucleotide substitutions and 77 indels were iden-
tiﬁed. Because the numbers were extremely high compared to those
of the preceding studies, we examined the positions of all the genotypes
that exhibited disagreement between the two lines (Fig. 1). Among
these sites, 845 single-nucleotide and 69 indel sites were located on
the long arm of chromosome 9. All the called genotypes were homozy-
gous without exception. Using an Illumina HumanCytoSNP-12 v2.1 DNA
Analysis BeadChip Kit, we also performed a SNP-genotyping analysis to
examine the existence of structural alterations. Copy-neutral loss of het-
erozygosity was detected in the 9:71,035,938–138,893,874 region
(GRCh37) of the iPS cell line, indicating that a large structural mutation
formed uniparental disomy. In that case, heterozygous sites in the region
became homozygous. The 914 sites in the exome-target regions were
considered to be just heterozygous in the progenitor cell, but not individ-
ualmutations. The SNP-genotyping analysis also suggested one copy-gain
mutation around 16:83,939,438–85,567,156 only in the iPS cell line, butno genotype disagreement was found in this 1.6-Mb region. Among the
remaining 77 single-nucleotide substitutions, C-to-T or G-to-A transitions
accounted for 29 of the changes.
3. Discussion
It is well known that C-to-T or G-to-A transitions in a dipyrimidine
context are typical type of UV-speciﬁc mutations [7]. A trinucleotide
analysis revealed that TCT, TCC, TCA, and their complementary trinucle-
otides, inwhich themutated base is situated in the center, are frequently
subject to mutation. Partially due to the relatively low number of muta-
tions, the signiﬁcance of the mutation type in the sample was not deter-
mined. In addition to the fact that we failed to ﬁnd crucial mutations in
XP-related genes in the exome-target regions, the donor of the ﬁbroblast
might be affected by another type of XP. It could be possible that some of
the mutations that we identiﬁed in both of the lines are responsible for
the phenotype.
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